Skip to main content

Complex Regional Pain Syndromes

1
Pipeline Programs
5
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Sandoz
SandozAustria - Kundl
1 program
1
Zoledronic acidPhase 21 trial
Active Trials
NCT01788176Unknown40Est. Dec 2016
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
A2M enriched plasmaN/A1 trial
Active Trials
NCT04066933Unknown60Est. Dec 2023
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Evoked fields before and after a local blockN/A1 trial
Active Trials
NCT00217243Completed60Est. Jun 2007
Magnus Medical
Magnus MedicalCA - Burlingame
1 program
Evoked fields before and after a local blockN/A
Pfizer
PfizerNEW YORK, NY
1 program
PregabalinN/A1 trial
Active Trials
NCT00891397Terminated14Est. Oct 2010

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
SandozZoledronic acid
Angeles TherapeuticsA2M enriched plasma
PfizerPregabalin
Human BioSciencesEvoked fields before and after a local block

Clinical Trials (4)

Total enrollment: 174 patients across 4 trials

NCT01788176SandozZoledronic acid

The Use of Zoledronic Acid to Complex Regional Pain Syndrome

Start: Dec 2013Est. completion: Dec 201640 patients
Phase 2Unknown
NCT04066933Angeles TherapeuticsA2M enriched plasma

Forms of Cervical Brachial Syndrome Treated With Plasma Concentrate Enriched for A2M

Start: Sep 2018Est. completion: Dec 202360 patients
N/AUnknown
NCT00891397PfizerPregabalin

Pregabalin Versus Placebo as an Add on for Complex Regional Pain Syndrome (CPRS) of the Upper Limb Managed by Stellate Ganglion Block (The PREGA Study)

Start: Nov 2007Est. completion: Oct 201014 patients
N/ATerminated
NCT00217243Human BioSciencesEvoked fields before and after a local block

Evoked Fields After Median and Ulnar Stimulation

Start: Jun 2005Est. completion: Jun 200760 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.